dc.creatorMARTINEZ-ROSSI, Nilce M.
dc.creatorPERES, Nalu T. A.
dc.creatorROSSI, Antonio
dc.date.accessioned2012-10-19T23:00:35Z
dc.date.accessioned2018-07-04T15:17:49Z
dc.date.available2012-10-19T23:00:35Z
dc.date.available2018-07-04T15:17:49Z
dc.date.created2012-10-19T23:00:35Z
dc.date.issued2008
dc.identifierMYCOPATHOLOGIA, v.166, n.5/Jun, p.369-383, 2008
dc.identifier0301-486X
dc.identifierhttp://producao.usp.br/handle/BDPI/24487
dc.identifier10.1007/s11046-008-9110-7
dc.identifierhttp://dx.doi.org/10.1007/s11046-008-9110-7
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1621215
dc.description.abstractAlthough fungi do not cause outbreaks or pandemics, the incidence of severe systemic fungal infections has increased significantly, mainly because of the explosive growth in the number of patients with compromised immune system. Thus, drug resistance in pathogenic fungi, including dermatophytes, is gaining importance. The molecular aspects involved in the resistance of dermatophytes to marketed antifungals and other cytotoxic drugs, such as modifications of target enzymes, over-expression of genes encoding ATP-binding cassette (ABC) transporters and stress-response-related proteins are reviewed. Emphasis is placed on the mechanisms used by dermatophytes to overcome the inhibitory action of terbinafine and survival in the host environment. The relevance of identifying new molecular targets, of expanding the understanding about the molecular mechanisms of resistance and of using this information to design new drugs or to modify those that have become ineffective is also discussed.
dc.languageeng
dc.publisherSPRINGER
dc.relationMycopathologia
dc.rightsCopyright SPRINGER
dc.rightsrestrictedAccess
dc.subjectAntimycotic
dc.subjectDermatophytes
dc.subjectDrug resistance
dc.subjectMycoses
dc.subjectTarget
dc.subjectTerbinafine
dc.titleAntifungal Resistance Mechanisms in Dermatophytes
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución